Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial

J. Andrew Bird, Jonathan M. Spergel, Stacie M. Jones, Rima Rachid, Amal H. Assa'ad, Julie Wang, Stephanie A. Leonard, Susan S. Laubach, Edwin H. Kim, Brian P. Vickery, Benjamin P. Davis, Jennifer Heimall, Antonella Cianferoni, Andrew J. MacGinnitie, Elena Crestani, A. Wesley Burks

Research output: Contribution to journalArticlepeer-review

105 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences